In early 2020, the COVID-19 pandemic created a fast-moving, widespread public health crisis. In May 2020, PCORI expanded its PCORI Health Care Horizon Scanning System (HCHSS) to elucidate the landscape of potentially impactful applications for COVID-19. The HCHSS COVID-19 supplement scans for, identifies, monitors, and reports on emerging and available COVID-19-related treatments, diagnostics, preventive measures, management strategies, and systems changes with potential for high impact to patient outcomes—for individuals and populations—in the United States in the next 12 months.
Learn more about the Biweekly COVID-19 scans.
This Biweekly Scan focuses on CovGENE Prognostic Blood Test to Predict COVID-19 Severity and Temelimab to Treat Neuropsychiatric Post-COVID-19 Conditions.